Annual ROE:
33.08%-43.47%(-56.79%)Summary
- As of today, PTCT annual return on equity is 33.08%, with the most recent change of -43.47% (-56.79%) on December 31, 2024.
- During the last 3 years, PTCT annual ROE has risen by +249.83% (+115.26%).
- PTCT annual ROE is now -79.46% below its all-time high of 161.06%, reached on December 31, 2022.
Performance
PTCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-98.90%-27.20%(-37.94%)Summary
- As of today, PTCT quarterly return on equity is -98.90%, with the most recent change of -27.20% (-37.94%) on June 30, 2025.
- Over the past year, PTCT quarterly ROE has dropped by -155.93% (-273.42%).
- PTCT quarterly ROE is now -123.18% below its all-time high of 426.59%, reached on September 30, 2022.
Performance
PTCT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PTCT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -56.8% | -273.4% |
| 3Y3 Years | +115.3% | +98.9% |
| 5Y5 Years | +162.1% | -30.5% |
PTCT ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -79.5% | +115.3% | -123.2% | at low |
| 5Y | 5-Year | -79.5% | +115.3% | -123.2% | +98.9% |
| All-Time | All-Time | -79.5% | +104.7% | -123.2% | +98.9% |
PTCT ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -98.90%(-37.9%) |
| Mar 2025 | - | -71.70%(-298.7%) |
| Dec 2024 | 33.08%(-56.8%) | 36.09%(-25.4%) |
| Sep 2024 | - | 48.38%(-15.2%) |
| Jun 2024 | - | 57.03%(-27.1%) |
| Mar 2024 | - | 78.21%(-21.2%) |
| Dec 2023 | 76.55%(-52.5%) | 99.22%(-20.6%) |
| Sep 2023 | - | 124.92%(-18.6%) |
| Jun 2023 | - | 153.47%(-18.5%) |
| Mar 2023 | - | 188.26%(-28.7%) |
| Dec 2022 | 161.06%(+174.3%) | 264.06%(-38.1%) |
| Sep 2022 | - | 426.59%(+104.6%) |
| Jun 2022 | - | -9218.07%(-1683.4%) |
| Mar 2022 | - | -516.88%(-112.6%) |
| Dec 2021 | -216.75%(-166.2%) | -243.11%(-69.6%) |
| Sep 2021 | - | -143.35%(-50.6%) |
| Jun 2021 | - | -95.17%(-0.0%) |
| Mar 2021 | - | -95.13%(-16.7%) |
| Dec 2020 | -81.42%(-52.9%) | -81.49%(-6.0%) |
| Sep 2020 | - | -76.91%(-1.5%) |
| Jun 2020 | - | -75.81%(-44.7%) |
| Mar 2020 | - | -52.39%(-8.7%) |
| Dec 2019 | -53.24%(-5.4%) | -48.19%(-4.2%) |
| Sep 2019 | - | -46.26%(+12.9%) |
| Jun 2019 | - | -53.14%(+2.0%) |
| Mar 2019 | - | -54.25%(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -50.51%(+11.8%) | -48.85%(-37.7%) |
| Sep 2018 | - | -35.48%(-3.1%) |
| Jun 2018 | - | -34.42%(+28.1%) |
| Mar 2018 | - | -47.85%(+16.1%) |
| Dec 2017 | -57.24%(+30.4%) | -57.04%(+28.0%) |
| Sep 2017 | - | -79.17%(-1.6%) |
| Jun 2017 | - | -77.95%(+13.4%) |
| Mar 2017 | - | -89.96%(-7.3%) |
| Dec 2016 | -82.24%(-26.5%) | -83.85%(-0.6%) |
| Sep 2016 | - | -83.39%(-5.8%) |
| Jun 2016 | - | -78.85%(-10.1%) |
| Mar 2016 | - | -71.62%(-10.6%) |
| Dec 2015 | -65.00%(-50.8%) | -64.78%(-13.9%) |
| Sep 2015 | - | -56.85%(-8.2%) |
| Jun 2015 | - | -52.52%(-10.9%) |
| Mar 2015 | - | -47.36%(-11.6%) |
| Dec 2014 | -43.10%(+47.3%) | -42.45%(+3.7%) |
| Sep 2014 | - | -44.08%(-30.2%) |
| Jun 2014 | - | -33.85%(+4.5%) |
| Mar 2014 | - | -35.46%(+12.7%) |
| Dec 2013 | -81.86%(+88.4%) | -40.61%(-24.0%) |
| Sep 2013 | - | -32.74%(+57.3%) |
| Jun 2013 | - | -76.59%(+49.5%) |
| Mar 2013 | - | -151.77%(-541.6%) |
| Dec 2012 | -708.63%(-455.5%) | 34.37% |
| Dec 2011 | -127.57% | - |
FAQ
- What is PTC Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual ROE year-on-year change?
- What is PTC Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly ROE year-on-year change?
What is PTC Therapeutics, Inc. annual return on equity?
The current annual ROE of PTCT is 33.08%
What is the all-time high annual ROE for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual return on equity is 161.06%
What is PTC Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, PTCT annual return on equity has changed by -43.47% (-56.79%)
What is PTC Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of PTCT is -98.90%
What is the all-time high quarterly ROE for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly return on equity is 426.59%
What is PTC Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, PTCT quarterly return on equity has changed by -155.93% (-273.42%)